Have an account? Log in.
I don't have an account.
https://www.medicaid.gov/federal-policy-guidance/downloads/sho26001.pdf
Top Wall Street analysts changed outlook on top names. See complete rating changes, including upgrades and downgrades, on Benzinga's analyst ratings page.
Evercore ISI Group analyst Elizabeth Anderson initiates coverage on Elevance Health (NYSE:ELV) with a In-Line rating and announces Price Target of $345.
Elevance Health is surging Tuesday after federal regulators finalized a sizable increase in 2027 Medicare Advantage reimbursement rates.
Medicare Advantage stocks surge as CMS finalizes 2027 rates. Read about the 2.48% base rate hike and the impact on CVS, UNH, and ALHC.
CMS raises Medicare Advantage payments by 2.48% for 2027, boosting insurer stocks after stronger-than-expected rate decision.
Health insurer stocks are surging after the market close on Monday, following the Centers for Medicare and Medicaid Services' (CMS) finalization of payment policies for 2027.
https://www.cms.gov/newsroom/press-releases/cms-finalizes-2027-medicare-advantage-part-d-paymen
The Starter plan only unlocks analyses for the 25 stocks tracked over the past month. With the Compact plan, you get access to all stocks from Germany and the USA – with Premium, worldwide access.